You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
- 2. Cardiovascular adverse effects of immunotherapy in cancer: insights and implications
- 3. Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics
- 4. Fusobacterium nucleatum promotes metastasis of breast cancer via the miR-21-3p/FOXO3 axis
- 5. A pan-cancer analysis of the prognostic and immunological roles of zinc finger protein 514 in human tumors
- 6. Singlera Genomics and Partners publish results from GUIDE prospective cohort study demonstrating blood-based early detection of gastrointestinal cancers using DNA methylation-based GutSeer assay
- 7. Amplia Therapeutics achieves second complete response with narmafotinib in pancreatic cancer trial
- 8. Development and validation of hybrid machine learning approach for predicting survival in patients with cervical cancer: a SEER-based population study
- 9. Human annexin A5 promotes glioma progression by targeting the MAPK/CD44 pathway
- 10. PreciseDx Secures $11M in New Funding
Last updated at 18:43 GMT
Hot News Makers
Health/Pharma Companies
- 867592.90
- 26415.87
- 10915.51
- 7733.36
- 6854.71
- 6083.55
- 6077.49
- 5684.03
- 5129.59
- 4434.26
Drugs, Treatments, Trials
- 11701.06
- 5665.12
- 3536.55
- 3198.12
- 2704.23
- 2051.31
- 1859.60
- 1648.04
- 1434.91
- 1289.06
Last updated at 18:10 GMT
